Why Does Breast Cancer Happen? Causes, Genetic Risks, and Modern Testing
At a Glance
- Sample Required: Blood or saliva (for genetic testing)
- Fasting Rules: No fasting required
- Turnaround Time (TAT): 10–14 business days for BRCA analysis
- Base Cost: [Insert Current 2026 Price]
Understanding Breast Cancer
Breast cancer arises when cells in the breast tissue undergo uncontrolled division and growth, forming a tumor. If left unchecked, the tumor can invade adjacent tissues and metastasize through the lymphatic or circulatory systems. The exact etiology is multifactorial, involving an interplay of genetic, environmental, and lifestyle factors. While the precise cause remains elusive, significant advances in molecular diagnostics have clarified the role of hereditary mutations, particularly in the BRCA1 and BRCA2 genes.
Known Risk Factors for Breast Cancer
The following risk factors are well-established in clinical literature. It is crucial to note that having one or more risk factors does not guarantee a breast cancer diagnosis; conversely, many women diagnosed have no identifiable risk factors.
- Age: The incidence increases with age, particularly after 50 years.
- Gender: Female sex is the strongest risk factor; male breast cancer accounts for less than 1% of cases.
- Family History: A first-degree relative with breast or ovarian cancer elevates risk, especially if diagnosed premenopausally.
- Genetic Mutations: Pathogenic variants in BRCA1, BRCA2, PALB2, TP53, and others confer high lifetime risks.
- Personal History: Prior breast cancer increases the risk of contralateral disease.
- Reproductive Factors: Early menarche (<12 years), late menopause (>55 years), nulliparity, and first pregnancy after 30 years are associated with increased risk.
- Lifestyle Factors: Alcohol consumption, obesity, physical inactivity, and exposure to ionizing radiation or endocrine-disrupting chemicals contribute to risk.
Genetic Predisposition: BRCA1 and BRCA2
Approximately 5–10% of breast cancer cases are hereditary, with BRCA1 and BRCA2 mutations accounting for the majority. These tumor suppressor genes are involved in DNA double-strand break repair. Pathogenic variants lead to genomic instability and increased cancer risk. In 2026, genetic testing for these genes is performed using Next-Generation Sequencing (NGS) and Whole Exome Sequencing (WES), which offer high sensitivity and the ability to detect large rearrangements that older Sanger sequencing might miss.
Women with a BRCA1 mutation have a 55–72% lifetime risk of breast cancer, while BRCA2 carriers face a 45–69% risk. Additionally, these mutations elevate ovarian cancer risk. Genetic counseling is strongly recommended before and after testing to interpret results and discuss management strategies.
When to Consider Genetic Testing
The National Comprehensive Cancer Network (NCCN) guidelines recommend genetic testing for individuals with:
- Breast cancer diagnosed at age ≤50 years
- Triple-negative breast cancer diagnosed at age ≤60 years
- Two or more primary breast cancers
- Known family history of BRCA-related cancers
- Male breast cancer at any age
- Ashkenazi Jewish ancestry with a personal or family history of breast/ovarian cancer
Information Gain: Risk Factor Comparison
| Risk Factor | Relative Impact | Modifiable? | Clinical Action |
|---|---|---|---|
| Age | High | No | Screening mammography |
| BRCA1/2 mutation | Very High | No | Genetic testing, risk-reducing surgery |
| Alcohol consumption | Moderate | Yes | Limit intake |
| Obesity | Moderate | Yes | Weight management |
| Nulliparity | Low-Moderate | No | Enhanced surveillance |
Screening and Diagnostic Modalities
Early detection remains paramount. Mammography, ultrasound, and MRI are standard imaging tools. For individuals with high genetic risk, annual MRI is recommended in addition to mammography. Tissue biopsy with histopathological analysis confirms diagnosis. Molecular profiling, including hormone receptor status and HER2 expression, guides targeted therapy.
Prevention and Lifestyle Modifications
While not all risk factors are modifiable, evidence-based strategies include maintaining a healthy weight, limiting alcohol, engaging in regular physical activity, and considering chemoprevention (e.g., tamoxifen) for high-risk individuals. For BRCA carriers, risk-reducing bilateral mastectomy and salpingo-oophorectomy are options that reduce cancer incidence but require careful counseling.
Why Choose DNA Labs India?
DNA Labs India is an ISO 9001 certified laboratory offering comprehensive genetic testing for hereditary breast cancer. Our state-of-the-art NGS platform ensures accurate and timely results. We provide genetic counseling support to help you understand your risk and make informed decisions.
Written by: Dr. Ananya Sharma, PhD, Medical Geneticist
Medically Reviewed by: Dr. Rajesh Kumar, MD, Pathologist
Last Updated: March 2026

